Patents Issued in July 1, 2014
-
Patent number: 8765421Abstract: A method for producing coenzyme Q10 by using stock culture from solid phase fermentation. The strain used in this method is Rhodobacter sphaeroides. Strain passaging is carried out by culturing in a slant medium. After steam cooking and air drying, solid medium is subpackaged and sterilized, wherein said solid medium includes solid components and liquid components. The fresh culture of Rhodobacter sphaeroides on the slant medium is added with sterile water, and the resultant bacterial suspension is added into the solid medium, cultured and used as stock culture for primary fermentation. The method of the present invention can enhance the fermentation level of coenzyme Q10, reduce the cascades of fermentation, shorten production cycle, simplify production processes, and lower production cost.Type: GrantFiled: April 26, 2011Date of Patent: July 1, 2014Assignee: Xiamen Kingdomway Group CompanyInventors: Jinqing Chen, Dajun Chen, Junhuang Chen, Meiqiong Wu, Songgang Su, Jianzhong Huang, Yi Zheng
-
Patent number: 8765422Abstract: Disclosed are methods and compositions related to ONC-T18, D4-desaturases, D5 elongases, their isolation, characterization, production, identification, and use for fatty acid production, as well as organisms containing these compositions and organisms expressing them.Type: GrantFiled: October 31, 2007Date of Patent: July 1, 2014Assignee: DSM Nutritional Products AGInventors: Adam Burja, Gabrielle S. Chafe, Helia Radianingtyas
-
Patent number: 8765423Abstract: It is an object to provide a novel diacylglycerol acyltransferase. The present invention relates to a diacylglycerol acyltransferase, a polynucleotide encoding the same, and so on. The present invention provides a polynucleotide comprising the nucleotide sequence of, e.g., SEQ ID NO: 1 or 4, a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2, an expression vector and transformant comprising the polynucleotide, a method for producing a lipid or fatty acid composition using the transformant, or a food, etc. comprising the lipid or fatty acid produced by the method.Type: GrantFiled: December 20, 2010Date of Patent: July 1, 2014Assignee: Suntory Holdings LimitedInventor: Misa Ochiai
-
Patent number: 8765424Abstract: Methods and compositions for the production of oil, fuels, oleochemicals, and other compounds in recombinant microorganisms are provided, including oil-bearing microorganisms and methods of low cost cultivation of such microorganisms. Microalgal cells containing exogenous genes encoding, for example, a lipase, a sucrose transporter, a sucrose invertase, a fructokinase, a polysaccharide-degrading enzyme, a keto acyl-ACP synthase enzyme, a fatty acyl-ACP thioesterase, a fatty acyl-CoA/aldehyde reductase, a fatty acyl-CoA reductase, a fatty aldehyde reductase, a fatty aldehyde decarbonylase, and/or an acyl carrier protein are useful in manufacturing transportation fuels such as renewable diesel, biodiesel, and renewable jet fuel, as well as oleochemicals such as functional fluids, surfactants, soaps and lubricants.Type: GrantFiled: July 6, 2012Date of Patent: July 1, 2014Assignee: Solazyme, Inc.Inventors: Scott Franklin, Aravind Somanchi, Janice Wee, George Rudenko, Jeffrey L. Moseley, Walt Rakitsky
-
Patent number: 8765425Abstract: Disclosed herein are methods of producing alcohol esters during a fermentation by providing alcohol-producing microorganisms which further comprise an engineered polynucleotide encoding a polypeptide having lipase activity.Type: GrantFiled: March 23, 2012Date of Patent: July 1, 2014Assignee: Butamax Advanced Biofuels LLCInventors: Robert Dicosimo, Arthur Leo Kruckeberg, Thomas Edwin Van Aken
-
Patent number: 8765426Abstract: Zymomonas is unable to synthesize pantothenic acid and requires this essential vitamin in growth medium. Zymomonas strains transformed with an operon for expression of 2-dehydropantoate reductase and aspartate 1-decarboxylase were able to grow in medium lacking pantothenic acid. These strains may be used for ethanol production without pantothenic acid supplementation in seed culture and fermentation media.Type: GrantFiled: March 29, 2012Date of Patent: July 1, 2014Assignee: E I du Pont de Nemours and CompanyInventors: Luan Tao, Jean-Francois Tomb, Paul V. Viitanen
-
Patent number: 8765427Abstract: This invention provides a method for producing ethanol from mannitol using yeast and a yeast strain that produces ethanol from mannitol. The method for producing ethanol from mannitol comprises culturing yeast strains capable of mannitol assimilation and ethanol production from mannitol in a medium containing mannitol.Type: GrantFiled: February 29, 2012Date of Patent: July 1, 2014Assignee: Maruha Nichiro Holdings, Inc.Inventors: Kousaku Murata, Shigeyuki Kawai, Hiroshi Oda, Keishi Iohara
-
Patent number: 8765428Abstract: The present invention is directed to a process for biologically converting carbohydrates from lignocellulosic biomass comprising the steps of: suspending lignocellulosic biomass in a flow-through reactor, passing a reaction solution into the reactor, wherein the solution is absorbed into the biomass substrate and at least a portion of the solution migrates through said biomass substrate to a liquid reservoir, recirculating the reaction solution in the liquid reservoir at least once to be absorbed into and migrate through the biomass substrate again. The biological converting of the may involve hydrolyzing cellulose, hemicellulose, or a combination thereof to form oligosaccharides, monomelic sugars, or a combination thereof; fermenting oligosaccharides, monomelic sugars, or a combination thereof to produce ethanol, or a combination thereof. The process can further comprise removing the reaction solution and processing the solution to separate the ethanol produced from non-fermented solids.Type: GrantFiled: July 17, 2009Date of Patent: July 1, 2014Assignee: Mascoma CorporationInventors: Christopher D. Herring, Chaogang Liu, John Bardsley
-
Patent number: 8765429Abstract: Methods and apparatus for treating biomass that may include introducing a biomass to a chamber; exposing the biomass in the chamber to a shock event to produce a shocked biomass; and transferring the shocked biomass from the chamber. In some aspects, the method may include pretreating the biomass with a chemical before introducing the biomass to the chamber and/or after transferring shocked biomass from the chamber.Type: GrantFiled: March 28, 2012Date of Patent: July 1, 2014Assignee: The Texas A & M University SystemInventors: Mark T. Holtzapple, Maxine Jones Madison, Rocio Sierra Ramirez, Mark A Deimund, Matthew Falls, John J. Dunkleman
-
Patent number: 8765430Abstract: Provided are methods, systems, and compositions for increasing the rate and/or yield of fermentation processes using blended feedstocks. Also provided are methods, systems, and compositions for decreasing the yield of one or more undesirable products during fermentation.Type: GrantFiled: December 31, 2012Date of Patent: July 1, 2014Assignee: Sweetwater Energy, Inc.Inventors: Sarad Parekh, Carl P. Felice, Benjamin Stauber
-
Patent number: 8765431Abstract: Disclosed herein are methods of preparing alkenes from beta-hydroxy or beta-sulfate carboxylic acid or carboxylic acid derivatives using thioesterase and optionally a sulfotransferase.Type: GrantFiled: July 23, 2010Date of Patent: July 1, 2014Assignee: The Regents of the University of MichiganInventors: David H. Sherman, Janet L. Smith, Liangcai Gu, Jennifer Gehret
-
Patent number: 8765432Abstract: The present invention provides random copolymers containing phosphorylcholine and one or more functional agents, and methods of preparing such random copolymers.Type: GrantFiled: May 10, 2010Date of Patent: July 1, 2014Assignee: Oligasis, LLCInventors: Stephen A. Charles, D. Victor Perlroth
-
Patent number: 8765433Abstract: The invention relates to suitable candidate alcohol dehydrogenase (ADH) enzymes for production of lower alkyl alcohols including isobutanol. The invention also relates to recombinant host cells that comprise such ADH enzymes and methods for producing lower alkyl alcohols in the same.Type: GrantFiled: December 29, 2010Date of Patent: July 1, 2014Assignee: Butamax Advanced Biofuels LLCInventors: Sriram Satagopan, Daniel P. O'Keefe, Janardhan Gude
-
Patent number: 8765434Abstract: The object is to provide a novel glycosyltransferase and the use thereof, the glycosyltransferase catalyzes transglucosylation of maltotriose units under conditions which can be employed for the processing of foods or the like. Provided is a maltotriosyl transferase which acts on polysaccharides and oligosaccharides having ?-1,4 glucoside bonds, and has activity for transferring maltotriose units to saccharides, the maltotriosyl transferase acting on maltotetraose as substrate to give a ratio between the maltoheptaose production rate and maltotriose production rate of 9:1 to 10:0 at any substrate concentration ranging from 0.67 to 70% (w/v).Type: GrantFiled: September 11, 2013Date of Patent: July 1, 2014Assignee: Amano Enzyme Inc.Inventors: Masamichi Okada, Shotaro Yamaguchi, Miho Nagoya
-
Patent number: 8765435Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.Type: GrantFiled: July 11, 2011Date of Patent: July 1, 2014Assignee: Roche Molecular Systems, Inc.Inventors: Keith Bauer, Fred Reichert, Thomas W. Myers
-
Patent number: 8765436Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.Type: GrantFiled: July 11, 2011Date of Patent: July 1, 2014Assignee: Roche Molecular Systems, Inc.Inventors: Keith Bauer, Fred Reichert, Thomas W. Myers
-
Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof
Patent number: 8765437Abstract: This invention provides compositions of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase (GALNS), and pharmaceutical compositions and formulations thereof, methods of producing and purifying GALNS, and its use in the diagnosis, prophylaxis, or treatment of diseases and conditions, including particularly lysosomal storage diseases that are caused by, or associated with, a deficiency in the GALNS enzyme, e.g., Mucopolysaccharidosis IVa (MPS IVa or Morquio A syndrome).Type: GrantFiled: July 22, 2011Date of Patent: July 1, 2014Assignee: Biomarin Pharmaceutical Inc.Inventors: Vish Koppaka, Michel Claude Vellard, Augustus O. Okhamafe, Kidisti Araya -
Patent number: 8765438Abstract: Polypeptides with xylanase activity modified to increase bran solubilization and/or xylanase activity. The modification comprises modification of one or more amino acids in position 12 or 13 in combination with one or more further amino acid modifications in position 15, 34, 54, 77, 81, 82, 99, 104, 110, 113, 114, 118, 122, 141, 154, 159, 162, 164, 166, 175 or 179, wherein the positions are determined as the position corresponding the position of Bacillus subtilis xylanase (SEQ ID NO 1).Type: GrantFiled: December 23, 2009Date of Patent: July 1, 2014Assignee: DuPont Nutrition Biosciences ApSInventors: Ole Sibbesen, Jens Frisbæk Sørensen
-
Patent number: 8765439Abstract: A maltogenic ?-amylase from Trichoderma reesei (TrAA) and variants thereof in the presence of a glucoamylase are useful in the production of high-glucose syrups from liquefied starch, where the high-glucose syrups produced thereby contain at least about 97% glucose. In this process, TrAA advantageously suppresses the reversion of glucose to malto-oligosaccharides. Expression hosts and encoding nucleic acids useful for producing TrAA and its variants also are provided.Type: GrantFiled: October 19, 2012Date of Patent: July 1, 2014Assignee: Danisco US Inc.Inventors: Gang Duan, Kathy Qian, Martijn Scheffers, Jayarama K. Shetty, Pieter Van Solingen
-
Patent number: 8765440Abstract: Disclosed are a number of homologs and variants of Hypocrea jecorina Cel7A (formerly Trichoderma reesei cellobiohydrolase I or CBH1), nucleic acids encoding the same and methods for producing the same. The homologs and variant cellulases have the amino acid sequence of a glycosyl hydrolase of family 7A wherein one or more amino acid residues are substituted and/or deleted.Type: GrantFiled: March 25, 2011Date of Patent: July 1, 2014Assignee: Danisco US Inc.Inventors: Frits Goedegebuur, Peter Gualfetti, Colin Mitchinson, Paulien Neefe
-
Patent number: 8765441Abstract: The invention provides novel biologically pure cultures of microorganisms high in protease activity and capable of decomposing proteins recalcitrant to proteolysis as contained in garbage, waste water, organic waste liquids, industrial wastes and the like, a protease produced by such microorganisms and capable of decomposing proteins recalcitrant to proteolysis, and a method of utilizing the same. The novel culture is of a soil-derived microorganism belonging to Streptomyces sp., or a strain derived therefrom, which produces a protease capable of efficiently decomposing proteins recalcitrant to proteolysis as contained in waste water, organic waste liquids, industrial wastes and so forth.Type: GrantFiled: August 9, 2011Date of Patent: July 1, 2014Assignee: Microbial Chemistry Research FoundationInventors: Hiroyasu Doi, Naoko Kinoshita, Tatsuzo Oka, Zhao Hui
-
Patent number: 8765442Abstract: The invention relates to a process for production of an enzyme product having a plurality of enzyme activities obtained by fermentation of an Aspergillus strain.Type: GrantFiled: December 21, 2009Date of Patent: July 1, 2014Assignee: DuPont Nutrition Biosciences ApSInventor: Mette Zacho Grønfeldt
-
Patent number: 8765443Abstract: Disclosed herein are a crystal of a human TOPII (hTOPII)-DNA binary complex, the method for preparing the same and the use thereof. The hTOPII-DNA binary complex includes an hTOPII portion that contains an hTOPII core domain (hTOPIIcore), and a synthetic double-stranded DNA in complex with the hTOPII portion. The synthetic double-stranded DNA has a first DNA strand comprising nucleotide positions 3 to 20 of the sequence of 5?-NNNCCGAGCNNNNGCTCGGNNN-3? (SEQ ID NO: 1), wherein N is any one of adenine, thymine, cytosine, or guanine, and a second DNA strand complementary to the first DNA strand.Type: GrantFiled: July 24, 2012Date of Patent: July 1, 2014Assignee: National Taiwan UniversityInventors: Nei-Li Chan, Tsai-Kun Li, Chyuan-Chuan Wu, Ying-Ren Wang
-
Patent number: 8765444Abstract: Provided herein are methods and compositions for use in treating HSV-related conditions and diseases.Type: GrantFiled: July 15, 2010Date of Patent: July 1, 2014Assignee: The Board of Trustees of the University of IllinoisInventors: Bin He, Dustin Verpooten, Yijie Ma
-
Patent number: 8765445Abstract: The present invention provides an equol-producing lactic acid bacteria-containing composition comprising, as an essential component thereof, a lactic acid bacterial strain belonging to the genus Lactococcus having an ability to utilize at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein to produce equol. Such a composition is effective for the prevention and alleviation of malaise inclusive of climacteric disturbance in middle-aged and elderly women for which no effective prophylactic method or alleviating means has heretofore been available.Type: GrantFiled: June 29, 2004Date of Patent: July 1, 2014Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Shigeto Uchiyama, Tomomi Ueno, Toshimi Suzuki
-
Patent number: 8765446Abstract: The present invention relates to recombinant mutant microorganisms having an increased ability to produce alcohol and a method of producing alcohol using the same, and more particularly to recombinant mutant microorganisms which have an increased ability to produce butanol, ethanol, isopropanol or mixed alcohols, which can be used as fuel, while producing little or no producing acetone as a byproduct, and to a method of producing butanol, ethanol, isopropanol or mixed alcohols using the same. The inventive recombinant mutant microorganisms having an increased ability to produce butanol or mixed alcohols and to remove acetone are those in which genes that encode enzymes involved in producing butanol from butyryl-CoA or butylaldehyde and in producing isopropanol from acetone were amplified or introduced in host microorganisms.Type: GrantFiled: September 21, 2010Date of Patent: July 1, 2014Assignees: Korea Advanced institute of Science and Technology, Biofuelchem Co., GS Caltex CorporationInventors: Sang Yup Lee, Yu-Sin Jang, Joung Min Lee, Jung Ae Im, Hyohak Song
-
Patent number: 8765447Abstract: A fungal strain Beauveria species bearing accession number MTCC 5184 is disclosed. The process for the preparation of an enzyme mix including at least one enzyme selected from, but not limited to protease, carbohydrase, and lipase from the disclosed Beauveria species and uses of the enzyme mix in various areas also disclosed.Type: GrantFiled: February 4, 2011Date of Patent: July 1, 2014Assignee: Council of Scientific and Industrial ResearchInventors: Seeta Laxman Ryali, Shiv Shankar, Snehal Vijay More, Harish Bansilal Khandelwal, Chandra Babu Kannan Narasimhan, Saravanan Palanivel, Padmanabhan Balaram
-
Patent number: 8765448Abstract: Methods and means are provided for the exact exchange in eukaryotic cells, such as plant cells, of a target DNA sequence for a DNA sequence of interest through homologous recombination, whereby the selectable or screenable marker used during the homologous recombination phase for temporal selection of the gene replacement events can subsequently be removed without leaving a foot-print employing a method for the removal of a selected DNA flanked by two nucleotide sequences in direct repeats.Type: GrantFiled: June 3, 2008Date of Patent: July 1, 2014Assignee: Bayer Cropscience, N.V.Inventors: Anne Rolland, Manuel Dubald, Michiel Van Lookeren Campagne, Rene Ruiter
-
Patent number: 8765449Abstract: A three stage, multiple phase anaerobic digestion system and method designed to separate the biological phases, optimize microbial activity in each phase, and significantly increase system reliability and energy production. The system physically separates the biological phases of anaerobic digestion based on particle size, particle density, and solubility of metabolic products. The system allows a complex multi-phased biological system to develop without the need for excessive control or operator intervention.Type: GrantFiled: July 31, 2009Date of Patent: July 1, 2014Assignee: Advanced Bio Energy Development LLCInventor: William C Stewart
-
Patent number: 8765450Abstract: The present invention relates to compositions and methods for the bioremediation of hydrocarbon-containing waste, such as drill mud and drill cuttings from oil and gas wellbores, drill waste deposit sites, oil spills, oil and gas production waste, and contaminated surfaces, using wood chips comprising microorganisms of mountain pine beetle.Type: GrantFiled: February 27, 2013Date of Patent: July 1, 2014Assignee: Confluence Energy, LLCInventor: Mark Joseph Mathis
-
Patent number: 8765451Abstract: The present invention provides a method of treating an off-gas stream (80) comprising NH3 and H2S to provide a sulphate stream (910), the method comprising the steps of: (i) providing a first off-gas stream (80) comprising NH3, H2S, CO2 and optionally one or more of HCN, COS and CS2; (ii) passing the first off-gas stream (80) to an incinerator (300) to oxidize NH3, H2S, and optionally one or more of HCN, COS and CS2 to provide a second off-gas stream (310) comprising N2, H2O, SO2 and CO2; (iii) scrubbing the second off-gas stream (310) with a first aqueous alkaline stream (380, 876a) in a caustic scrubber (350) to separate SO2 and a part of the CO2 from the second off-gas stream to provide a spent caustic stream (360) comprising carbonate and one or both of sulphite and bisulphite and a caustic scrubber off-gas stream (370) comprising N2 and CO2; and (iv) passing the spent caustic stream (360) to an aerator (900) comprising sulphur-oxidizing bacteria in the presence of oxygen to biologically oxidize sulphiteType: GrantFiled: April 6, 2010Date of Patent: July 1, 2014Assignee: Shell Oil CompanyInventor: Sandra Schreuder
-
Patent number: 8765452Abstract: Devices, systems and methods for increasing fermentation rates of microbes via biostimulation are provided. Electrodes are preferably positioned along an interior or exterior of a tube-shaped component to administer electromagnetic/electric pulses to a solution comprising a microbe. Systems can advantageously be used in new biofuels production plants, or in existing biofuels production plants without the need for significant retrofits.Type: GrantFiled: December 26, 2012Date of Patent: July 1, 2014Assignee: Colorado Energy Research Technologies, LLCInventors: Wayne J. Powell, Robert D. Boehmer, Lee L. Johnson, Ken Swartz, Donald E. Lenci
-
Patent number: 8765453Abstract: Provided is a system and method for staining of one or more samples, including providing one or more self-contained sample processing receptacles, each of the one or more self-contained sample processing receptacles configured to be inserted into an auto-staining instrument; and enabling one of one or more staining procedures appropriate for the one or more samples as a function of a choice of self-contained sample processing receptacle, each of the one or more self-contained sample processing receptacles configured to process each inserted sample of the one or more samples within the self-contained sample processing receptacle.Type: GrantFiled: December 19, 2011Date of Patent: July 1, 2014Assignee: SYFR, Inc.Inventors: Shazi S Iqbal, Steven M Montgomery, Ronald Chang, Gregory E Mote, Douglas B Dority, Jeffrey S Ross
-
Patent number: 8765454Abstract: The present invention describes microfluidic devices that provide novel fluidic structures to facilitate the separation of fluids into isolated, pico-liter sized compartments for performing multiplexing chemical and biological reactions. Applications of the novel devices including biomolecule synthesis, polynucleotide amplification, and binding assays are also disclosed.Type: GrantFiled: February 18, 2005Date of Patent: July 1, 2014Inventors: Xiaochuan Zhou, Xiaollan Gao, Erdogan Gulari
-
Patent number: 8765455Abstract: A non-contact system for sorting monodisperse water-in-oil emulsion droplets in a microfluidic device based on the droplet's contents and their interaction with an applied electromagnetic field or by identification and sorting.Type: GrantFiled: January 27, 2011Date of Patent: July 1, 2014Assignees: Lawrence Livermore National Security, LLC, The Regents of the University of CaliforniaInventors: Neil Reginald Beer, Abraham Lee, Andrew Hatch
-
Patent number: 8765456Abstract: The invention relates to microscale cell separating apparatus which are able to separate cells on the basis of size of the cells, interaction of the cells with surfaces of the apparatus, or both. The apparatus comprises a stepped or sloped separation element (16) interposed between an inlet region (20) and an outlet region (22) of a void that can be tilled with fluid. The void can be enclosed within a cover (12) and fluid flow through the void engages cells with the separation element. Only cells which have (or can deform to have) a characteristic dimension smaller than or equal to the distance between a step and the cover or body can pass onto or past a step. Modifications of surfaces within the apparatus can also inhibit passage of cells onto or past a step.Type: GrantFiled: June 28, 2011Date of Patent: July 1, 2014Assignee: Parsortix, Inc.Inventor: Georgi Hvichia
-
Patent number: 8765457Abstract: A device for assay can evenly develop solution, and performs highly accurate and sensitive measurement. A first device part (10) maintains a second insoluble carrier (12) and a third insoluble carrier (13) in such a manner that they overlap with each other at a detection portion (14) of a first insoluble carrier (11). These three carriers (11), (12) and (13) are housed not in contact with each other. A pressing unit (18) having a pressing surface (18a) that is parallel to the detection portion (14) is provided on an inner surface of the second device part (20) facing the detection portion (14). The pressing surface (18a) is displaced by being pressed toward the detection portion (14), and presses, from the upper side of the first insoluble carrier (11), the second insoluble carrier (12) and the third insoluble carrier (13) onto the first insoluble carrier (11). The first device part (10) and the second device part (20) are joined together.Type: GrantFiled: March 30, 2010Date of Patent: July 1, 2014Assignee: FUJIFILM CorporationInventors: Mikinaga Mori, Junichi Katada, Takayoshi Oyamada, Hideyuki Karaki, Masayasu Konishi, Hiroki Terada
-
Patent number: 8765458Abstract: The invention provides coated sensors for detecting the presence of analytes. The sensor comprises one or more fluorescent sources, such as one or more quantum dots or one or more fluorescent dyes, a polymeric matrix, a surface coating, and one or more analyte sensing components. The surface coating may be a conformal polymeric film, permeable to the analyte, which may be deposited via a solventless process such as initiated chemical vapor deposition or photoinitiated chemical vapor deposition. The surface coating may increase the biocompatibility of the sensor, reduce nonspecific protein adsorption, and/or sequester functional sensor components within the sensor. The invention also provides methods for detecting the presence of an analyte with coated sensors of the invention.Type: GrantFiled: May 29, 2013Date of Patent: July 1, 2014Assignees: The Charles Stark Draper Laboratory, Inc., Massachusetts Institute of TechnologyInventors: Heather A. Clark, Karen K. Gleason, Salmaan Baxamusa, John M. Dubach
-
Patent number: 8765459Abstract: The invention provides systems and methods for manipulating biological systems, for example to elicit a more desired biological response from a biological sample, such as a tissue, organ, and/or a cell. In one aspect, the invention operates by efficiently searching through a large parametric space of stimuli and system parameters to manipulate, control, and optimize the response of biological samples sustained in the system. In one aspect, the systems and methods of the invention use at least one optimization algorithm to modify the actuator's control inputs for stimulation, responsive to the sensor's output of response signals. The invention can be used, e.g., to optimize any biological system, e.g., bioreactors for proteins, and the like, small molecules, polysaccharides, lipids, and the like. Another use of the apparatus and methods includes is for the discovery of key parameters in complex biological systems.Type: GrantFiled: July 30, 2012Date of Patent: July 1, 2014Assignee: The Regents of the University of CaliforniaInventors: Chih-Ming Ho, Pak Kin Wong, Ren Sun, Fuqu Yu
-
Patent number: 8765460Abstract: A photobioreactor system for mass production of microorganisms is disclosed. Water with microorganisms suspended therein is sprayed through a nozzle to create droplets. These droplets have a high surface area to volume ratio enabling efficient light transfer and gas diffusion. The water may also be passed through channels between two transparent plates, wherein superior mixing is achieved along with a high surface to volume ratio. The water is preferably circulated through a dark holding tank Active and passive flashing lights of different wavelengths are used to promote growth of the microorganisms when the water is sprayed and/or passing through the transparent plates.Type: GrantFiled: December 13, 2010Date of Patent: July 1, 2014Inventors: Atle B. Nordvik, George Berliner
-
Patent number: 8765461Abstract: Disclosed is a novel HIV gene comprising a set of open reading frames encoded with the template as the plus strand of the proviral DNA, and located in the region of HIV-1 long terminal repeat. The genes encode a set of antisense proteins, (HAPs) as well as smaller proteins, related to, and containing structural motif resembling that of chemokine proteins. Depending upon the ribosomal frameshift, a plurality of proteins may be translated from the antisense RNA. The smaller proteins have similarity with chemokine SDF-1 and may play a role as a cofactor with gp120 in the binding to and entry of HIV to a target cell.Type: GrantFiled: April 30, 2002Date of Patent: July 1, 2014Inventor: Linda B. Ludwig
-
Patent number: 8765462Abstract: Compositions and methods for delivering immune modulatory molecules to result in a therapeutic effect are disclosed. The compositions and methods use stably integrating lentiviral delivery systems. The methods are useful for therapeutically and prophylactically treating cancer such as leukemia.Type: GrantFiled: May 5, 2008Date of Patent: July 1, 2014Assignee: University Health NetworkInventors: Jeffrey A. Medin, Christopher J. Paige
-
Patent number: 8765463Abstract: The present invention relates to oncolytic adenoviruses having therapeutic applications. Recombinant chimeric adenoviruses, and methods to produce them are provided. The chimeric adenoviruses of the invention comprise nucleic acid sequences derived from adenoviral serotypes classified within the subgroups B through F and demonstrate an enhanced therapeutic index.Type: GrantFiled: April 10, 2012Date of Patent: July 1, 2014Assignee: PsiOxus Therapeutics LimitedInventors: Paul Harden, Terry Hermiston, Irene Kuhn
-
Patent number: 8765464Abstract: The present invention provide: a novel process for culturing animal cells and a kit for culturing animal cells, in which, even if the number of cells as sampled for biopsy is extremely small, the proliferation can sufficiently be maintained so as to enable to carry out various culture and/or tests, especially anticancer agent sensitivity tests, and the contamination with bacteria can be inhibited without damaging physiological activity of cells, especially sensitivity to anticancer agents. The process for culturing animal cells, according to the present invention, comprises the step of culturing a sample containing animal cells obtained from living body tissue in order to subject the sample to further culture and/or a test, with the process being characterized in that a culture medium is used wherein the culture medium has a proliferating action and physiological activity-retaining action on the animal cells, and further has a killing action and/or multiplication-inhibition action on bacteria.Type: GrantFiled: June 22, 2007Date of Patent: July 1, 2014Assignee: Kurashiki Boseki Kabushiki KaishaInventors: Kazuhiko Minamigawa, Hisayuki Kobayashi, Toshikazu Takano
-
Patent number: 8765465Abstract: This invention relates to a method for producing cardiomyocytes and/or cardiac progenitor cells, comprising culturing an induced pluripotent stem (iPS) cell or embryonic stem (ES) cell, which has been differentiated into a mesoderm cell, in the presence of cyclosporin-A.Type: GrantFiled: August 29, 2008Date of Patent: July 1, 2014Assignee: Kyoto UniversityInventors: Jun Yamashita, Peishi Yan
-
Patent number: 8765466Abstract: The present invention relates to a method for increased production of a secreted, recombinant protein product through the introduction of molecular chaperones in a mammalian host cell. The present invention also relates to a mammalian host cell with enhanced expression of a secreted recombinant protein product by coexpressing at least one chaperone protein.Type: GrantFiled: March 13, 2013Date of Patent: July 1, 2014Assignee: Bayer Pharmaceuticals CorporationInventors: Sham-Yuen Chan, Hsinyi Yvette Tang, Yiwen Tao, Yongjian Wu, Ruth Kelly
-
Patent number: 8765467Abstract: Methods are provided for producing novel multicellular compositions comprising cancer cells together with pluripotent human stem cells, which are capable of proliferating and differentiating into various normal cell lines and tissue structures. These novel multicellular compositions are useful for investigating the properties of cancer cells in a normal human tissue microenvironment, and for studying interventions that will modulate these properties including devising, testing and screening therapeutic drugs.Type: GrantFiled: May 5, 2004Date of Patent: July 1, 2014Assignee: Technion Research and Development Foundation Ltd.Inventors: Karl L. Skorecki, Maty Tzukerman
-
Patent number: 8765468Abstract: A device, and method of making the device, capable of therapeutic treatment and/or for in vitro testing of human skin. The device may be used on skin wounds for burned, injured, or diseased skin, and provides structures and functions as in normal uninjured skin, such as barrier function, which is a definitive property of normal skin. The device contains cultured dermal and epidermal cells on a biocompatible, biodegradable reticulated matrix. All or part of the cells may be autologous, from the recipient of the cultured skin device, which advantageously eliminates concerns of tissue compatibility. The cells may also be modified genetically to provide one or more factors to facilitate healing of the engrafted skin replacement, such as an angiogenic factor to stimulate growth of blood vessels.Type: GrantFiled: May 24, 2013Date of Patent: July 1, 2014Assignees: University of Cincinnati, Shriners Hospitals for ChildrenInventor: Steven T. Boyce
-
Patent number: 8765469Abstract: A method for preparing lymphocytes characterized in that the method comprises the step of carrying out expansion in the presence of (a) fibronectin, a fragment thereof or a mixture thereof, (b) a CD3 ligand, and (c) a CD28 ligand.Type: GrantFiled: August 10, 2006Date of Patent: July 1, 2014Assignee: Takara Bio Inc.Inventors: Takahiro Marui, Kinuko Nagamine, Nobuko Muraki, Akiko Kato, Tatsuji Enoki, Hiroaki Sagawa, Ikunoshin Kato
-
Patent number: 8765470Abstract: Methods and composition for providing induced pluripotent stem (iPS) cells are provided. For example, in certain aspects methods including reprogramming B lymphocytes transformed by episomal vectors such as Epstein-Barr virus-based vectors are described. Furthermore, the invention provides induced pluripotent stem cells essentially free of exogenous elements and having B cell immunoglobin variable region rearrangement.Type: GrantFiled: August 3, 2011Date of Patent: July 1, 2014Assignee: Cellular Dynamics International, Inc.Inventors: James Thomson, Deepika Rajesh, Sarah Jane Dickerson, Amanda Mack, Michael Miller